Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Apr 1;159(4):1105-16.
doi: 10.1084/jem.159.4.1105.

Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization

M Tateno, N Kondo, T Itoh, T Chubachi, T Togashi, T Yoshiki

Rat lymphoid cell lines with human T cell leukemia virus production. I. Biological and serological characterization

M Tateno et al. J Exp Med. .

Abstract

Cocultivation of spleen cells, lymph node cells, and thymocytes of female Wistar-King-Aptekman rats with short-term cultured male adult T cell leukemia (ATL) cells in the presence of 5-bromo-2'-deoxyuridine (BrdUrd) resulted in the establishment of rat lymphoid cell lines, TARS-1, TARL-2, and TART-1. Cytogenetic analysis of the three cell lines showed a female rat karyotype with 42 chromosomes. The surface phenotypes of TARS-1 and TART-1 were those of rat T cells. TARL-2 was only positive for rat Ia and leukocyte common antigens. The cell lines continuously produced a type C retrovirus, human T cell leukemia virus (HTLV) and expressed ATL-associated antigens. TARS-1 and TART-1, but not TARL-2 were transplantable into newborn syngeneic rats and nude mice. These results strongly indicate that HTLV not only immortalizes, but also transforms rat T cells in vitro. Adult rats immunized with either TARS-1 or TARL-2 produced antibodies specific for HTLV. The biochemical analysis of the antigens that reacted with rat sera revealed that they are the two HTLV-specific polypeptides, p24 and p28.

PubMed Disclaimer

References

    1. J Immunol. 1972 Jul;109(1):32-7 - PubMed
    1. J Exp Med. 1974 Apr 1;139(4):925-42 - PubMed
    1. J Exp Med. 1974 Oct 1;140(4):1011-27 - PubMed
    1. J Virol. 1974 Nov;14(5):1274-80 - PubMed
    1. Blood. 1977 Sep;50(3):481-92 - PubMed

Publication types

MeSH terms